CLSI M33-A

Antiviral Susceptibility Testing: Herpes Simplex Virus by Plaque Reduction Assay; Approved Standard, M33AE

Clinical and Laboratory Standards Institute, 02/01/2004

Publisher: CLSI

File Format: PDF

$120.00$240.30

Description

Published:01/02/2004

Pages:39

This document provides a protocol for the performance of the plaque reduction assay for phenotypic antiviral susceptibility testing of herpes simplex virus.

More CLSI standard pdf

CLSI M59

Epidemiological Cutoff Values for Antifungal Susceptibility Testing, 2nd Edition, M59Ed2E

$90.00 $180.00

CLSI M07-Ed11 and M100-Ed28 Package

Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Eleventh Edition / Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Eighth Informational Supplement, M07Ed11E, M100Ed28E

$171.00 $342.00

CLSI EP37

Supplemental Tables for Interference Testing in Clinical Chemistry, 1st Edition, EP37Ed1E

$90.00 $180.00

CLSI EP07 (R2022)

Interference Testing in Clinical Chemistry; 3rd Edition, EP07Ed3E

$90.00 $180.00